Myosin Therapeutics Doses First Patient in Phase 1/2 STAR-GBM Trial for Novel Glioblastoma Therapy MT-125

Myosin Therapeutics, a clinical stage biotechnology company developing innovative therapies for oncology, announced that the first patient has been dosed...

May 21, 2026 | Thursday | News
Thermo Fisher Scientific Opens Advanced Bioanalytical and Biomarker Laboratory in Sweden

The state-of-the-art facility enhances support for complex modalities across all phases of drug development Key facts Thermo Fisher opens new bioanal...

May 21, 2026 | Thursday | News
From Outsourcing to Strategic Alignment: The Future of CRO Partnerships in Biotech Building CRO Partnerships That Drive Speed, Continuity, and Clinical Success

As clinical development grows more complex and globally interconnected, biotech companies are under increasing pressure to build CRO partnerships that deli...

May 15, 2026 | Friday | Interaction
Inside the Sterile Manufacturing Boom: Symbiosis Expands Capacity for the Next Generation of Biopharma

  As biologics, advanced therapies, and specialised injectable medicines continue to reshape the pharmaceutical landscape, the demand for agile and h...

May 15, 2026 | Friday | Interaction
Thermo Fisher Launches Gibco™ CTS™ DynaXS™ Single Use Bioreactor to Advance Scalable Cell Therapy Manufacturing

  New Gibco™ CTS™ DynaXS™ Single Use Bioreactor supports flexible, cGMP-ready cell expansion from process development to clinical p...

May 06, 2026 | Wednesday | News
UCB to Acquire Candid Therapeutics in Up to $2.2 Billion Deal to Expand Next-Generation Immunology Portfolio

Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics with potential for i...

May 05, 2026 | Tuesday | News
Advancing Precision Radiotherapeutics for Hard-to-Treat CNS Cancers

  Central nervous system (CNS) cancers remain among the most difficult diseases to treat in oncology, with limited therapeutic options, complex deliv...

May 04, 2026 | Monday | Interaction
LTS LOHMANN Therapie-Systeme AG Expands CDMO Portfolio with U.S.-Based Ophthalmic Drug Delivery Services

LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company specializing in advanced drug delivery systems, announced the expans...

April 01, 2026 | Wednesday | News
TrialClinIQ Secures Pre-Seed Funding and Accelerator Backing to Advance Equitable Clinical Trial Access

TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, announced a $150K pre-seed investment fro...

April 30, 2026 | Thursday | News
Thermo Fisher Scientific Opens Flagship Bioprocess Design Center in Massachusetts to Accelerate Biologics Development

  Expansion of Plainville, Mass., facility offers bioprocessing expertise, advanced technologies and customized support Thermo Fisher Scientific Inc...

April 29, 2026 | Wednesday | News
AviadoBio Ltd. Licenses Novel AAV Capsid from Apertura Gene Therapy to Advance CNS Gene Therapy Pipeline

AviadoBio Ltd. (“AviadoBio”) and Apertura Gene Therapy (“Apertura”), a biotechnology company developing next-generation AAV capsi...

April 29, 2026 | Wednesday | News
AIDS Healthcare Foundation Presses Shareholders to Challenge Gilead Sciences Patent Strategy at 2026 AGM with Proposal 6

With Proposal #6, AIDS group urges shareholders to vote to request the company produce a report on the impact of extended patent exclusivities on patie...

April 29, 2026 | Wednesday | News
Repertoire Immune Medicines Doses First Patient in Phase 1/2 Trial of Novel TCR Bispecific RPTR-1-201 for Solid Tumors

Clinical trial will evaluate safety, tolerability and antitumor activity of Repertoire's novel off-the-shelf T cell receptor (TCR) bispecific therapy as ...

April 27, 2026 | Monday | News
From Promise to Practice: Lance Alstodt on Advancing Scalable Stem Cell Therapies at BioRestorative Therapies, Inc.

Regenerative medicine is entering a pivotal phase, shifting from long-standing scientific promise toward practical clinical application. BioRestorative The...

April 27, 2026 | Monday | Interaction

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close